Altered levels of circulating natural antibodies against VEGFR1-derived peptide in atherosclerosis

BACKGROUND: Several lines of evidence have pointed to a protective role of natural antibodies in chronic diseases like atherosclerosis and cancer. Vascular endothelial growth factor receptor 1 (VEGFR1) and VEGFR2 are important regulators of angiogenesis and may be involved in the development of athe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peng, Liu, Siqi, Wang, Zhenqi, Zhao, Huan, Zhang, Xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513417/
https://www.ncbi.nlm.nih.gov/pubmed/32811267
http://dx.doi.org/10.1177/0300060520948750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513417/
https://www.ncbi.nlm.nih.gov/pubmed/32811267
http://dx.doi.org/10.1177/0300060520948750

Ejemplares similares